RxDoctor Payments Data

Jennifer Skolnik, DPM

Podiatrist · Boston, MANPI 1578090775

Payments from drug & device makers

What this record shows

This record is dominated by education: $2,532 of the $3,768 with a category attached, or 67.2%. Liberty Surgical Inc. accounts for 67.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $1,332 and has fallen 70.5% since, to $393 in 2025.

$3,768in general payments, 2019–2025

Across 16 payments — averaging $235.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Liberty Surgical Inc.$3K
  • Johnson & Johnson$276
  • Smith+Nephew$259
  • Stryker$196
  • Paragon 28, Inc.$149
  • Ossio Inc$141
  • plus $197 from 3 others

What the payments were for

  • Food & beverage$1,23633%
  • Education$2,53267%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,768 in reported general payments places this provider in the 80th percentile of 179 podiatrist providers in Massachusetts.

See all podiatrist providers in Massachusetts

Medicare billing

Part B allowed, 2024
$109,192
Medicare patients
535
Services billed
1,228

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JubliaEfinaconazole16$22,954
Ciclopirox90$3,693
Ammonium Lactate156$2,364
CiclopiroxCiclopirox Olamine77$2,047
Ketoconazole55$1,247
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip13$463
Imiquimod11$404
Diclofenac Sodium15$370
Doxycycline Monohydrate18$218
Terbinafine Hcl19$191
Oxycodone Hcl23$145
Silver Sulfadiazine18$132
Cephalexin12$64
Ibuprofen11$30

Paid to pharmacies, not to this prescriber.

Other podiatrist in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →